Your browser doesn't support javascript.
loading
Correlation of the refined Hurley classification for hidradenitis suppurativa with patient-reported quality of life and objective disease severity assessment.
Rondags, A; van Straalen, K R; van Hasselt, J R; Janse, I C; Ardon, C B; Vossen, A R J V; Prens, E P; van der Zee, H H; Horváth, B.
Affiliation
  • Rondags A; Department of Dermatology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • van Straalen KR; Department of Dermatology, Erasmus Medical Center, Rotterdam, the Netherlands.
  • van Hasselt JR; Department of Dermatology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Janse IC; Department of Dermatology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Ardon CB; Department of Dermatology, Meander Medical Center, Amersfoort, the Netherlands.
  • Vossen ARJV; Department of Dermatology, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Prens EP; Department of Dermatology, Erasmus Medical Center, Rotterdam, the Netherlands.
  • van der Zee HH; Department of Dermatology, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Horváth B; Department of Dermatology, Erasmus Medical Center, Rotterdam, the Netherlands.
Br J Dermatol ; 180(5): 1214-1220, 2019 05.
Article in En | MEDLINE | ID: mdl-30512186
ABSTRACT

BACKGROUND:

Hidradenitis suppurativa (HS) is a chronic, debilitating, heterogeneous disease requiring different treatment approaches. Recently, we refined the classic Hurley classification into a seven-stage classification in order to guide these treatment choices. This new classification subdivides Hurley stage I and II into three substages, namely mild (A), moderate (B) and severe (C) HS disease. Hurley stage III is not subcategorized and is always severe.

OBJECTIVES:

To investigate the correlation between the given severity grades of Hurley I and Hurley II in the refined Hurley classification, and the patient-reported quality of life and physician-assessed objective severity score. MATERIALS AND

METHODS:

In this cross-sectional study, patients with HS participating in the observational cohorts of two Dutch tertiary referral centres were included before June 2017. The patient-reported Dermatology Life Quality Index (DLQI) and physician-assessed International HS Severity Score System (IHS4) scores were compared between the refined Hurley stages.

RESULTS:

In total, 433 patients were analysed. DLQI and IHS4 scores increased within Hurley stage I and II from A through C. There was a significant positive correlation of DLQI and IHS4 with increasing refined Hurley substages [refined Hurley stage I (A, B and C) to DLQI rs = 0·259, P < 0·001 and refined Hurley stage II (A, B and C) to DLQI rs = 0·185, P = 0·010; refined Hurley stage I (A, B and C) to IHS4 rs = 0·603, P < 0·001 and refined Hurley stage II (A, B and C) to IHS4 rs = 0·532, P < 0·001].

CONCLUSIONS:

The refined Hurley classification accurately correlates with HS severity assessed by both patients and clinicians. Therefore, the refined Hurley classification is a useful tool for the quick assessment of severity in HS.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Severity of Illness Index / Hidradenitis Suppurativa / Patient Reported Outcome Measures Type of study: Clinical_trials / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Br J Dermatol Year: 2019 Type: Article Affiliation country: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Severity of Illness Index / Hidradenitis Suppurativa / Patient Reported Outcome Measures Type of study: Clinical_trials / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Br J Dermatol Year: 2019 Type: Article Affiliation country: Netherlands